FDA takes the lead on defin­ing es­sen­tial un­der Trump's 'Buy Amer­i­can' ex­ec­u­tive or­der — as phar­ma warns of sup­ply chain dis­rup­tion

Pres­i­dent Don­ald Trump has signed an ex­ec­u­tive or­der de­tail­ing how the fed­er­al gov­ern­ment should help on-shore drug man­u­fac­tur­ing — and the FDA will play a cen­tral role.

The agency now has three months to draw up the list of “es­sen­tial med­i­cines, med­ical coun­ter­mea­sures, and their crit­i­cal in­puts” that the US must have avail­able at all times. Var­i­ous de­part­ments and agen­cies are then di­rect­ed to buy these drugs and their in­gre­di­ents from Amer­i­can man­u­fac­tur­ers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER